{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:36:17Z","timestamp":1786995377552,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013594","name":"Alpha Foundation for the Improvement of Mine Safety and Health Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001448","name":"Alpha-1 Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008538","name":"Primary Sclerosing Cholangitis Partners Seeking a Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009052","name":"Polo delle Scienze e delle Tecnologie per la Vita, Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12376412"],"award-info":[{"award-number":["PNRR-MR1-2022-12376412"]}],"id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtn.2025.102593","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T11:17:19Z","timestamp":1749467839000},"page":"102593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatocyte delivery of miR-34b\/c reduces hepatic stellate cell activation and improves liver fibrosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Pasquale","family":"Piccolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Ferriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Nusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"De Cegli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolina Cristina","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Viscomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Cariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severo","family":"Campione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-8819","authenticated-orcid":false,"given":"Nicola","family":"Brunetti-Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102593_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102593_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0034-1397348","article-title":"Circulating microRNAs: emerging biomarkers of liver disease","volume":"35","author":"Arrese","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.omtn.2025.102593_bib3","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/hep.29627","article-title":"MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis","volume":"67","author":"Caviglia","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2025.102593_bib4","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/0008-5472.CAN-14-1254","article-title":"miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells","volume":"75","author":"Zhang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2025.102593_bib5","doi-asserted-by":"crossref","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","article-title":"The autoregulatory feedback loop of microRNA-21\/programmed cell death protein 4\/activation protein-1 (MiR-21\/PDCD4\/AP-1) as a driving force for hepatic fibrosis development","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102593_bib6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/mt.2016.127","article-title":"MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice","volume":"24","author":"Matsumoto","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102593_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2025.102593_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/hep4.1290","article-title":"Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis","volume":"3","author":"Chen","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.omtn.2025.102593_bib9","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.26768","article-title":"Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2025.102593_bib10","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1172\/JCI122258","article-title":"Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223","volume":"129","author":"Calvente","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102593_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.30645","article-title":"MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes","volume":"70","author":"He","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2025.102593_bib12","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025242118","article-title":"Up-regulation of miR-34b\/c by JNK and FOXO3 protects from liver fibrosis","volume":"118","author":"Piccolo","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102593_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-019-1059-5","article-title":"MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2025.102593_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2018.11.001","article-title":"MicroRNA-34\/449 family and viral infections","volume":"260","author":"Lv","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.omtn.2025.102593_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570524","article-title":"The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice","volume":"11","author":"Song","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2025.102593_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4939-6786-5_19","article-title":"Optimized Mouse Models for Liver Fibrosis","volume":"1559","author":"Kim","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102593_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102593_bib18","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2025.102593_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtn.2025.102593_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2011.06.002","article-title":"Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates","volume":"104","author":"Bell","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2025.102593_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.omtm.2021.04.010","article-title":"Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids","volume":"21","author":"Cabanes-Creus","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102593_bib22","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ajpath.2020.06.006","article-title":"Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-\u03b1 Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury","volume":"190","author":"Kikuchi","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2025.102593_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12964-018-0306-2","article-title":"Selective deletion of hepatocyte platelet-derived growth factor receptor \u03b1 and development of liver fibrosis in mice","volume":"16","author":"Lim","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2025.102593_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2016.03.004","article-title":"Exosomes in liver pathology","volume":"65","author":"Sato","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102593_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/138920209788185225","article-title":"Epigenetic Control of MicroRNA Expression and Aging","volume":"10","author":"Liang","year":"2009","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.omtn.2025.102593_bib26","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/09168451.2017.1308242","article-title":"MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice","volume":"81","author":"Hong","year":"2017","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.omtn.2025.102593_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10993","article-title":"MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression","volume":"7","author":"Hyun","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102593_bib28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1742-4658.2011.08075.x","article-title":"The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"278","author":"Li","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.omtn.2025.102593_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016081","article-title":"The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families","volume":"6","author":"Murakami","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102593_bib30","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.12659\/MSM.894000","article-title":"MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1","volume":"21","author":"Yan","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.omtn.2025.102593_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158657","article-title":"Activation of the miR-34a\/SIRT1\/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102593_bib32","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.ajpath.2017.08.027","article-title":"Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury","volume":"187","author":"Wan","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2025.102593_bib33","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cellsig.2011.11.008","article-title":"Peroxisome proliferator-activated receptor-gamma cross-regulation of signaling events implicated in liver fibrogenesis","volume":"24","author":"Zhang","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.omtn.2025.102593_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1461505","article-title":"Therapeutic effects of serum extracellular vesicles in liver fibrosis","volume":"7","author":"Chen","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2025.102593_bib35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jhep.2021.12.015","article-title":"Modern therapeutic approaches to liver-related disorders","volume":"76","author":"Gardin","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102593_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14712598.2020.1817375","article-title":"Liver-directed gene-based therapies for inborn errors of metabolism","volume":"21","author":"Piccolo","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2025.102593_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JHD-200002","article-title":"Huntington's Disease Clinical Trials Corner: April 2020","volume":"9","author":"Rodrigues","year":"2020","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.omtn.2025.102593_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine. Molecular therapy","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nucleic acids"},{"key":"10.1016\/j.omtn.2025.102593_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102593_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S2468-1253(16)30205-9","article-title":"Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review","volume":"2","author":"Harris","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102593_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S2468-1253(16)30110-8","article-title":"Antifibrotics in chronic liver disease: tractable targets and translational challenges","volume":"1","author":"Ramachandran","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2025.102593_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102593_bib43","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2025.102593_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002797","article-title":"Intact p53-dependent responses in miR-34-deficient mice","volume":"8","author":"Concepcion","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2025.102593_bib45","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1096\/fj.12-209379","article-title":"The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis","volume":"26","author":"Hochrath","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2025.102593_bib46","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","author":"Ikenaga","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.omtn.2025.102593_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/hgtb.2013.155","article-title":"AAV2\/8 vectors purified from culture medium with a simple and rapid protocol transduce murine liver, muscle, and retina efficiently","volume":"24","author":"Doria","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtn.2025.102593_bib48","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102593_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.omtn.2025.102593_bib50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtn.2025.102593_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14892-x","article-title":"A Comparison of mRNA Sequencing with Random Primed and 3'-Directed Libraries","volume":"7","author":"Xiong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102593_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2025.102593_bib53","unstructured":"Bushnell, B. BBMap. https:\/\/sourceforge.net\/projects\/bbmap\/."},{"key":"10.1016\/j.omtn.2025.102593_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2025.102593_bib55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2025.102593_bib56","unstructured":"Alexa, A., and Rahnenfuhrer, J. (2019). topGO: Enrichment Analysis for Gene Ontology. R package version 1.38.1. https:\/\/10.18129\/B9.bioc.topGO."},{"key":"10.1016\/j.omtn.2025.102593_bib57","unstructured":"Hennig, C. Cran-package fpc. https:\/\/cran.r-project.org\/web\/packages\/fpc\/index.html."},{"key":"10.1016\/j.omtn.2025.102593_bib58","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102593_bib59","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2015-309655","article-title":"A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.omtn.2025.102593_bib60","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:24:30Z","timestamp":1777321470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2162253125001477"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102593","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte delivery of miR-34b\/c reduces hepatic stellate cell activation and improves liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102593"}}